Tag

GLP-1

Page 3 of 4

A person sitting on the edge of a bed with hands on their knees

Stopping GLP-1 drugs tracked with more anxiety after

A Nature Metabolism study of Shanghai health records found GLP-1 drugs carried no extra psychiatric risk during treatment, but higher risk of depression and anxiety after people stopped.

Jul 28, 2026

Overlapping blister packs holding many different coloured tablets and capsules

News

Semaglutide led the field for antipsychotic weight gain

A JAMA Psychiatry network meta-analysis of 95 trials ranked 39 drugs for reversing antipsychotic weight gain, and semaglutide came out well ahead at nearly 11 kg.

Jul 27, 2026

Masked surgeons working under theatre lights during an operation

News

Bariatric surgery cost less downstream than GLP-1 drugs

A JAMA Network Open study matched 2,721 pairs of Israeli patients over up to 12.5 years and found those on GLP-1 drugs ran up $109 more per month in other health costs than surgery patients.

Jul 27, 2026

A hand operating the control panel of an ultrasound scanner

News

Survodutide cleared liver fat in 84% of patients

A Nature Medicine phase 3 trial of 216 adults found survodutide cut liver fat by at least 30% in 84.2% of those treated, against 24.3% on placebo, alongside 12.2% weight loss.

Jul 27, 2026